CorMedix Inc. will join the Nasdaq Biotechnology Index effective December 23, 2024, reflecting its market performance.Quiver AI SummaryCorMedix Inc., a biopharmaceutical company focusing on treatments...
CorMedix highlights CMS policy changes increasing access to innovative therapies for hemodialysis patients starting January 2025.Quiver AI SummaryCorMedix Inc. has announced the recent policy changes by...
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, November 8:CorMedix Inc. CRMD: This biopharmaceutical company has a Zacks Rank #1 and witnessed...
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:Sappi Limited SPPJY: This wood fiber-based renewable resources company has seen the Zacks Consensus Estimate for its current year...
CRMD earnings call for the period ending September 30, 2024.